Ligand validation:3HYV

LMT: DODECYL-BETA-D-MALTOSIDE

LMT is a Ligand Of Interest in 3HYV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HYV_LMT_E_600	9%	60%	0.249	0.738	0.53	0.98	-	3	8	0	100%	0.5
3HYV_LMT_F_600	7%	62%	0.248	0.708	0.49	0.97	-	1	11	0	100%	0.5
3HYV_LMT_C_600	7%	59%	0.231	0.685	0.52	1.05	-	4	3	0	100%	0.5
3HYV_LMT_A_600	7%	61%	0.249	0.7	0.53	0.94	-	2	0	0	100%	0.5
3HYV_LMT_D_600	4%	64%	0.282	0.665	0.48	0.88	-	1	0	0	100%	0.5
3HYV_LMT_B_600	3%	49%	0.289	0.616	0.62	1.33	1	4	0	0	100%	0.5
3HYX_LMT_D_600	2%	52%	0.388	0.686	0.86	1	2	1	4	0	100%	0.5
3HYW_LMT_D_600	0%	64%	0.415	0.466	0.49	0.88	-	2	1	0	100%	0.5
5NV9_LMT_A_504	99%	31%	0.045	0.983	0.57	2.12	-	12	1	0	100%	1
3CAY_LMT_A_512	99%	59%	0.04	0.975	0.66	0.9	-	1	0	0	100%	1
7M78_LMT_L_202	95%	44%	0.073	0.976	1.13	1.04	3	2	0	0	100%	1
3T2Y_LMT_A_501	83%	30%	0.085	0.943	1.26	1.54	3	10	2	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.